PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
ARK Genomic Revolution Multi-Sector ETF (ARKG)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

ETF Info

ISINUS00214Q3020
CUSIP00214Q302
IssuerARK Investment Management
Inception DateOct 31, 2014
RegionNorth America (U.S.)
CategoryHealth & Biotech Equities, Actively Managed
Index TrackedNo Index (Active)
Home Pageark-funds.com
Asset ClassEquity

Asset Class Size

Multi-Cap

Asset Class Style

Growth

Expense Ratio

The ARK Genomic Revolution Multi-Sector ETF has a high expense ratio of 0.75%, indicating higher-than-average management fees.


Expense ratio chart for ARKG: current value at 0.75% compared with the broader market ranging from 0.00% to 2.12%.0.50%1.00%1.50%2.00%0.75%

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


ARK Genomic Revolution Multi-Sector ETF

Popular comparisons: ARKG vs. ARKK, ARKG vs. XBI, ARKG vs. GNOM, ARKG vs. IBB, ARKG vs. BBH, ARKG vs. IDNA, ARKG vs. ARKQ, ARKG vs. SWPPX, ARKG vs. QQQ, ARKG vs. SPY

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in ARK Genomic Revolution Multi-Sector ETF, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-10.00%0.00%10.00%20.00%30.00%40.00%NovemberDecember2024FebruaryMarchApril
-1.11%
19.37%
ARKG (ARK Genomic Revolution Multi-Sector ETF)
Benchmark (^GSPC)

S&P 500

Returns By Period

ARK Genomic Revolution Multi-Sector ETF had a return of -26.91% year-to-date (YTD) and -20.39% in the last 12 months.


PeriodReturnBenchmark
Year-To-Date-26.91%6.30%
1 month-14.81%-3.13%
6 months-1.11%19.37%
1 year-20.39%22.56%
5 years (annualized)-5.36%11.65%
10 years (annualized)N/A10.55%

Monthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
2024-13.32%10.79%-8.73%
2023-13.61%-17.37%20.50%18.28%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of ARKG is 6, indicating that it is in the bottom 6% of the market in terms of risk-adjusted performance. This ranking is based on the combined values of the indicators listed below.

The Risk-Adjusted Performance Rank of ARKG is 66
ARK Genomic Revolution Multi-Sector ETF(ARKG)
The Sharpe Ratio Rank of ARKG is 66Sharpe Ratio Rank
The Sortino Ratio Rank of ARKG is 77Sortino Ratio Rank
The Omega Ratio Rank of ARKG is 77Omega Ratio Rank
The Calmar Ratio Rank of ARKG is 55Calmar Ratio Rank
The Martin Ratio Rank of ARKG is 55Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for ARK Genomic Revolution Multi-Sector ETF (ARKG) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


ARKG
Sharpe ratio
The chart of Sharpe ratio for ARKG, currently valued at -0.54, compared to the broader market-1.000.001.002.003.004.00-0.54
Sortino ratio
The chart of Sortino ratio for ARKG, currently valued at -0.59, compared to the broader market-2.000.002.004.006.008.00-0.59
Omega ratio
The chart of Omega ratio for ARKG, currently valued at 0.94, compared to the broader market1.001.502.000.94
Calmar ratio
The chart of Calmar ratio for ARKG, currently valued at -0.27, compared to the broader market0.002.004.006.008.0010.00-0.27
Martin ratio
The chart of Martin ratio for ARKG, currently valued at -0.99, compared to the broader market0.0010.0020.0030.0040.0050.0060.00-0.99
^GSPC
Sharpe ratio
The chart of Sharpe ratio for ^GSPC, currently valued at 1.92, compared to the broader market-1.000.001.002.003.004.001.92
Sortino ratio
The chart of Sortino ratio for ^GSPC, currently valued at 2.78, compared to the broader market-2.000.002.004.006.008.002.78
Omega ratio
The chart of Omega ratio for ^GSPC, currently valued at 1.33, compared to the broader market1.001.502.001.33
Calmar ratio
The chart of Calmar ratio for ^GSPC, currently valued at 1.47, compared to the broader market0.002.004.006.008.0010.001.47
Martin ratio
The chart of Martin ratio for ^GSPC, currently valued at 7.64, compared to the broader market0.0010.0020.0030.0040.0050.0060.007.64

Sharpe Ratio

The current ARK Genomic Revolution Multi-Sector ETF Sharpe ratio is -0.54. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00NovemberDecember2024FebruaryMarchApril
-0.54
1.92
ARKG (ARK Genomic Revolution Multi-Sector ETF)
Benchmark (^GSPC)

Dividends

Dividend History

ARK Genomic Revolution Multi-Sector ETF granted a 0.00% dividend yield in the last twelve months. The annual payout for that period amounted to $0.00 per share.


PeriodTTM2023202220212020201920182017
Dividend$0.00$0.00$0.00$0.38$0.79$1.05$0.47$0.33

Dividend yield

0.00%0.00%0.00%0.62%0.85%3.14%1.94%1.34%

Monthly Dividends

The table displays the monthly dividend distributions for ARK Genomic Revolution Multi-Sector ETF. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


JanFebMarAprMayJunJulAugSepOctNovDec
2024$0.00$0.00$0.00
2023$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
2022$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
2021$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.38
2020$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.79
2019$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$1.05
2018$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.47
2017$0.33

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-80.00%-60.00%-40.00%-20.00%0.00%NovemberDecember2024FebruaryMarchApril
-78.54%
-3.50%
ARKG (ARK Genomic Revolution Multi-Sector ETF)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the ARK Genomic Revolution Multi-Sector ETF. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the ARK Genomic Revolution Multi-Sector ETF was 80.10%, occurring on Oct 27, 2023. The portfolio has not yet recovered.

The current ARK Genomic Revolution Multi-Sector ETF drawdown is 78.54%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-80.1%Jan 21, 2021698Oct 27, 2023
-37.44%Jun 23, 2015162Feb 11, 2016387Aug 29, 2017549
-35.09%Sep 4, 201877Dec 21, 201869Apr 3, 2019146
-34.99%Mar 9, 20206Mar 16, 202024Apr 20, 202030
-20.71%Jul 31, 201949Oct 8, 201949Dec 17, 201998

Volatility

Volatility Chart

The current ARK Genomic Revolution Multi-Sector ETF volatility is 10.35%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%5.00%10.00%15.00%NovemberDecember2024FebruaryMarchApril
10.35%
3.58%
ARKG (ARK Genomic Revolution Multi-Sector ETF)
Benchmark (^GSPC)